Scientific article

Prise en charge de la rhinite allergique au cabinet du généraliste

Published inRevue médicale suisse, vol. 19, no. 843, p. 1739-1742
Publication date2023-09-27

In Switzerland, almost 20 % of the population suffers from allergic rhinitis, which has a major impact on patients' quality of life. Allergen avoidance remains the most effective measure but is not always possible. Intranasal corticosteroids, oral antihistamines, or combination of intranasal corticosteroids and antihistamines remain first-line pharmacological treatments. In case of refractory symptoms, despite well-managed symptomatic treatment, when the patient wishes a more long-term effect or for prevention of asthma, the patient can be referred to the allergologist for specific immunotherapy. The specific immunotherapy is the only treatment option that targets the underlying pathophysiology of allergy and therefore shows disease-modifying effects.

Citation (ISO format)
LÄNZLINGER, Yoann et al. Prise en charge de la rhinite allergique au cabinet du généraliste. In: Revue médicale suisse, 2023, vol. 19, n° 843, p. 1739–1742. doi: 10.53738/REVMED.2023.19.843.1739
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 03/28/2025
ISSN of the journal1660-9379

Technical informations

Creation10/05/2023 1:19:19 PM
First validation02/21/2024 9:01:11 AM
Update time02/21/2024 9:01:11 AM
Status update02/21/2024 9:01:11 AM
Last indexation05/06/2024 5:58:32 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack